U.S. Farm Bill opens door on hemp; FDA to consider new cannabis policy

“ We recognize the potential opportunities that cannabis or cannabis-derived compounds could offer..."

The Food and Drug Administration said on Thursday it will consider creating new policy regarding the marketing and sale of cannabis after President Donald Trump signed the Farm Bill, which legalized commercial production of hemp in the United States.

The FDA said in a statement that it hopes to make more efficient “pathways” for companies to introduce and market cannabis and cannabis-derived products, including cannabidiol (CBD) into interstate commerce. 

“We recognize the potential opportunities that cannabis or cannabis-derived compounds could offer and acknowledge the significant interest in these possibilities,” FDA Commissioner Scott Gottlieb said in the statement, adding that the agency will hold a public meeting to gather input.


Hemp is a type of cannabis plant with no or extremely low concentrations of the psychoactive compound known as THC, the ingredient in marijuana associated with “high” feelings. 

The Farm Bill removed hemp from the Controlled Substances Act, allowing for its commercial production in the United States, as long as those plants contain no more than 0.3 percent of THC.


© 2020 Dr. Strains Co.® All Rights Reserved